Low-dose ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a review of 20 years' experience.
D000208:Acute Disease; D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011379:Prognosis
D003561:Cytarabine